Skip to main content
Erschienen in: Supportive Care in Cancer 1/2022

21.08.2021 | Original Article

Appropriate referral timing to specialized palliative care service: survey of bereaved families of cancer patients who died in palliative care units

verfasst von: Keita Tagami, Kento Masukawa, Akira Inoue, Tatsuya Morita, Yusuke Hiratsuka, Mamiko Sato, Katsura Kohata, Noriaki Satake, Yoshiyuki Kizawa, Satoru Tsuneto, Yasuo Shima, Mitsunori Miyashita

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Few studies have investigated appropriate referral timing of specialized palliative care (SPC) from the perspective of cancer patients’ and families’ experiences. We aimed to clarify appropriate SPC referral timing for patients with advanced cancer and their families. We used data from a nationwide bereaved family survey in Japan. We sent a questionnaire to 999 bereaved families of cancer patients who died in 164 palliative care units (PCUs) and analyzed the first SPC referral timing and how patients evaluated it. We defined SPC as outpatient or inpatient palliative care service comprising certified palliative care physicians, advanced-practice nurses, and multidisciplinary practitioners. Finally, 51.6% (n = 515) of all responses were analyzed. The SPC referral timing was evaluated as appropriate (26.1%), late or too late (20.2%), early or too early (1.2%), or none of these (52.5%). Of these, 32.3% reported that they were referred to an SPC when diagnosed with advanced or incurable cancer or during anti-cancer treatment, and 62.6% reported they were referred after anti-cancer treatment. Patient-perceived appropriateness of SPC referral timing was associated with their good death process. After excluding “none of these” responses, a significantly higher proportion of respondents who reported being referred to SPC at diagnosis and during anti-cancer treatment evaluated the response timing as appropriate, compared to those who reported being referred after anti-cancer treatment. Appropriate timing for SPC referrals relates to quality of death; findings suggest that appropriate timing is at the time of diagnosis or during anti-cancer treatment.
Literatur
1.
Zurück zum Zitat Hui D, Mori M, Watanabe SM et al (2016) Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol 17:e552–e559CrossRef Hui D, Mori M, Watanabe SM et al (2016) Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol 17:e552–e559CrossRef
2.
Zurück zum Zitat Hui D, Meng YC, Bruera S et al (2016) Referral criteria for outpatient palliative cancer care: a systematic review. Oncologist 21:895–901CrossRef Hui D, Meng YC, Bruera S et al (2016) Referral criteria for outpatient palliative cancer care: a systematic review. Oncologist 21:895–901CrossRef
3.
Zurück zum Zitat Wong A, Vidal M, Prado B et al (2019) Patients’ perspective of timeliness and usefulness of an outpatient supportive care referral at a comprehensive cancer center. J Pain Symptom Manage 58:275–281CrossRef Wong A, Vidal M, Prado B et al (2019) Patients’ perspective of timeliness and usefulness of an outpatient supportive care referral at a comprehensive cancer center. J Pain Symptom Manage 58:275–281CrossRef
4.
Zurück zum Zitat Morita T, Fujimoto K, Namba M et al (2008) Palliative care needs of cancer outpatients receiving chemotherapy: an audit of a clinical screening project. Support Care Cancer 16:101–107CrossRef Morita T, Fujimoto K, Namba M et al (2008) Palliative care needs of cancer outpatients receiving chemotherapy: an audit of a clinical screening project. Support Care Cancer 16:101–107CrossRef
5.
Zurück zum Zitat Glare PA, Semple D, Stabler SM et al (2011) Palliative care in the outpatient oncology setting: evaluation of a practical set of referral criteria. J Oncol Pract 7:366–370CrossRef Glare PA, Semple D, Stabler SM et al (2011) Palliative care in the outpatient oncology setting: evaluation of a practical set of referral criteria. J Oncol Pract 7:366–370CrossRef
6.
Zurück zum Zitat Wentlandt K, Krzyzanowska MK, Swami N et al (2012) Referral practices of oncologists to specialized palliative care. J Clin Oncol 30:4380–4386CrossRef Wentlandt K, Krzyzanowska MK, Swami N et al (2012) Referral practices of oncologists to specialized palliative care. J Clin Oncol 30:4380–4386CrossRef
7.
Zurück zum Zitat Ferrell BR, Temel JS, Temin S et al (2017) Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 35:96–112CrossRef Ferrell BR, Temel JS, Temin S et al (2017) Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 35:96–112CrossRef
8.
Zurück zum Zitat Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742CrossRef Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742CrossRef
9.
Zurück zum Zitat Zimmermann C, Swami N, Krzyzanowska M et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383:1721–1730CrossRef Zimmermann C, Swami N, Krzyzanowska M et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383:1721–1730CrossRef
10.
Zurück zum Zitat Bakitas MA, Tosteson TD, Li Z et al (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the enable iii randomized controlled trial. J Clin Oncol 33:1438–1445CrossRef Bakitas MA, Tosteson TD, Li Z et al (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the enable iii randomized controlled trial. J Clin Oncol 33:1438–1445CrossRef
11.
Zurück zum Zitat Temel JS, Greer JA, El-Jawahri A et al (2017) Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol 35:834–841CrossRef Temel JS, Greer JA, El-Jawahri A et al (2017) Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol 35:834–841CrossRef
12.
Zurück zum Zitat Temel JS, Jacobsen PB (2020) Palliative care in oncology: continuing to build the evidence base and disseminate effective care models. J Clin Oncol 38:849–851CrossRef Temel JS, Jacobsen PB (2020) Palliative care in oncology: continuing to build the evidence base and disseminate effective care models. J Clin Oncol 38:849–851CrossRef
13.
Zurück zum Zitat Masukawa K, Aoyama M, Morita T et al (2018) The Japan Hospice and Palliative Evaluation Study 4: a cross-sectional questionnaire survey. BMC Palliat Care 17:66CrossRef Masukawa K, Aoyama M, Morita T et al (2018) The Japan Hospice and Palliative Evaluation Study 4: a cross-sectional questionnaire survey. BMC Palliat Care 17:66CrossRef
14.
Zurück zum Zitat Hui D, Kim SH, Roquemore J et al (2014) Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer 120:1743–1749CrossRef Hui D, Kim SH, Roquemore J et al (2014) Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer 120:1743–1749CrossRef
15.
Zurück zum Zitat Morita T, Akechi T, Ikenaga M et al (2005) Late referrals to specialized palliative care service in Japan. J Clin Oncol 23:2637–2644CrossRef Morita T, Akechi T, Ikenaga M et al (2005) Late referrals to specialized palliative care service in Japan. J Clin Oncol 23:2637–2644CrossRef
16.
Zurück zum Zitat Morita T, Miyashita M, Tsuneto S et al (2009) Late referrals to palliative care units in Japan: nationwide follow-up survey and effects of palliative care team involvement after the cancer control act. J Pain Symptom Manage 38:191–196CrossRef Morita T, Miyashita M, Tsuneto S et al (2009) Late referrals to palliative care units in Japan: nationwide follow-up survey and effects of palliative care team involvement after the cancer control act. J Pain Symptom Manage 38:191–196CrossRef
17.
Zurück zum Zitat Costantini M, Toscani F, Gallucci M et al (1999) Terminal cancer patients and timing of referral to palliative care: a multicenter prospective cohort study. Italian cooperative research group on palliative medicine. J Pain Symptom Manage 18:243–252CrossRef Costantini M, Toscani F, Gallucci M et al (1999) Terminal cancer patients and timing of referral to palliative care: a multicenter prospective cohort study. Italian cooperative research group on palliative medicine. J Pain Symptom Manage 18:243–252CrossRef
18.
Zurück zum Zitat Sakashita A, Kizawa Y, Kato M et al (2018) Development of a standard for hospital-based palliative care consultation teams in Japan using a modified Delphi method. J Pain Symptom Manage 56:746-751.e745CrossRef Sakashita A, Kizawa Y, Kato M et al (2018) Development of a standard for hospital-based palliative care consultation teams in Japan using a modified Delphi method. J Pain Symptom Manage 56:746-751.e745CrossRef
19.
Zurück zum Zitat Sakashita A, Shutoh M, Sekine R et al (2019) Development of a consensus syllabus of palliative medicine for physicians in Japan using a modified Delphi method. Indian J Palliat Care 25:30–40PubMedPubMedCentral Sakashita A, Shutoh M, Sekine R et al (2019) Development of a consensus syllabus of palliative medicine for physicians in Japan using a modified Delphi method. Indian J Palliat Care 25:30–40PubMedPubMedCentral
20.
Zurück zum Zitat Péus D, Newcomb N, Hofer S (2013) Appraisal of the Karnofsky performance status and proposal of a simple algorithmic system for its evaluation. BMC Med Inform Decis Mak 13:72–72CrossRef Péus D, Newcomb N, Hofer S (2013) Appraisal of the Karnofsky performance status and proposal of a simple algorithmic system for its evaluation. BMC Med Inform Decis Mak 13:72–72CrossRef
21.
Zurück zum Zitat Miyashita M, Sanjo M, Morita T et al (2007) Good death in cancer care: a nationwide quantitative study. Ann Oncol 18:1090–1097CrossRef Miyashita M, Sanjo M, Morita T et al (2007) Good death in cancer care: a nationwide quantitative study. Ann Oncol 18:1090–1097CrossRef
22.
Zurück zum Zitat Hirai K, Miyashita M, Morita T et al (2006) Good death in Japanese cancer care: a qualitative study. J Pain Symptom Manage 31:140–147CrossRef Hirai K, Miyashita M, Morita T et al (2006) Good death in Japanese cancer care: a qualitative study. J Pain Symptom Manage 31:140–147CrossRef
23.
Zurück zum Zitat Miyashita M, Morita T, Sato K et al (2008) Good death inventory: a measure for evaluating good death from the bereaved family member’s perspective. J Pain Smptom Manage 35:486–498CrossRef Miyashita M, Morita T, Sato K et al (2008) Good death inventory: a measure for evaluating good death from the bereaved family member’s perspective. J Pain Smptom Manage 35:486–498CrossRef
24.
Zurück zum Zitat Miyashita M, Morita T, Sato K, Hirai K, Shima Y, Uchitomi Y (2008) Factors contributing to evaluation of a good death from the bereaved family member’s perspective. Psychooncology 17:612–620CrossRef Miyashita M, Morita T, Sato K, Hirai K, Shima Y, Uchitomi Y (2008) Factors contributing to evaluation of a good death from the bereaved family member’s perspective. Psychooncology 17:612–620CrossRef
25.
Zurück zum Zitat Mori M, Sasahara T, Morita T, Aoyama M, Kizawa Y, Tsuneto S, Shima Y, Miyashita M (2019) Achievement of a good death among young adult patients with cancer: analyses of combined data from three nationwide surveys among bereaved family members. Support Care Cancer 27:1519–1527CrossRef Mori M, Sasahara T, Morita T, Aoyama M, Kizawa Y, Tsuneto S, Shima Y, Miyashita M (2019) Achievement of a good death among young adult patients with cancer: analyses of combined data from three nationwide surveys among bereaved family members. Support Care Cancer 27:1519–1527CrossRef
26.
Zurück zum Zitat Yamamoto R, Kizawa Y, Nakazawa Y et al (2015) Outcome evaluation of the palliative care emphasis program on symptom management and assessment for continuous medical education: nationwide physician education project for primary palliative care in japan. J Palliat Med 18:45–49CrossRef Yamamoto R, Kizawa Y, Nakazawa Y et al (2015) Outcome evaluation of the palliative care emphasis program on symptom management and assessment for continuous medical education: nationwide physician education project for primary palliative care in japan. J Palliat Med 18:45–49CrossRef
27.
Zurück zum Zitat Yamamoto R, Kizawa Y, Nakazawa Y et al (2013) The palliative care knowledge questionnaire for peace: reliability and validity of an instrument to measure palliative care knowledge among physicians. J Palliat Med 16:1423–1428CrossRef Yamamoto R, Kizawa Y, Nakazawa Y et al (2013) The palliative care knowledge questionnaire for peace: reliability and validity of an instrument to measure palliative care knowledge among physicians. J Palliat Med 16:1423–1428CrossRef
28.
Zurück zum Zitat Nakazawa Y, Yamamoto R, Kato M et al (2018) Improved knowledge of and difficulties in palliative care among physicians during 2008 and 2015 in Japan: association with a nationwide palliative care education program. Cancer 124:626–635CrossRef Nakazawa Y, Yamamoto R, Kato M et al (2018) Improved knowledge of and difficulties in palliative care among physicians during 2008 and 2015 in Japan: association with a nationwide palliative care education program. Cancer 124:626–635CrossRef
29.
Zurück zum Zitat Sasahara T, Watakabe A, Aruga E et al (2014) Assessment of reasons for referral and activities of hospital palliative care teams using a standard format: a multicenter 1000 case description. J Pain Manage 47:579-587.e576 Sasahara T, Watakabe A, Aruga E et al (2014) Assessment of reasons for referral and activities of hospital palliative care teams using a standard format: a multicenter 1000 case description. J Pain Manage 47:579-587.e576
30.
Zurück zum Zitat Fujisawa D, Umemura S, Okizaki A et al (2020) Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trial. BMJ Open 10:e037759CrossRef Fujisawa D, Umemura S, Okizaki A et al (2020) Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trial. BMJ Open 10:e037759CrossRef
31.
Zurück zum Zitat Hoerger M, Greer JA, Jackson VA et al (2018) Defining the elements of early palliative care that are associated with patient-reported outcomes and the delivery of end-of-life care. J Clin Oncol 36:1096–1102CrossRef Hoerger M, Greer JA, Jackson VA et al (2018) Defining the elements of early palliative care that are associated with patient-reported outcomes and the delivery of end-of-life care. J Clin Oncol 36:1096–1102CrossRef
32.
Zurück zum Zitat Kaasa S, Loge JH, Aapro M et al (2018) Integration of oncology and palliative care: a lancet oncology commission. Lancet Oncol 19:e588–e653CrossRef Kaasa S, Loge JH, Aapro M et al (2018) Integration of oncology and palliative care: a lancet oncology commission. Lancet Oncol 19:e588–e653CrossRef
33.
Zurück zum Zitat Bakitas MA, El-Jawahri A, Farquhar M et al (2017) The team approach to improving oncology outcomes by incorporating palliative care in practice. J Oncol Pract 13:557–566CrossRef Bakitas MA, El-Jawahri A, Farquhar M et al (2017) The team approach to improving oncology outcomes by incorporating palliative care in practice. J Oncol Pract 13:557–566CrossRef
34.
Zurück zum Zitat Dalal S, Bruera S, Hui D et al (2016) Use of palliative care services in a tertiary cancer center. Oncologist 21:110–118CrossRef Dalal S, Bruera S, Hui D et al (2016) Use of palliative care services in a tertiary cancer center. Oncologist 21:110–118CrossRef
35.
Zurück zum Zitat Watanabe SM, Faily V, Mawani A et al (2020) Frequency, timing, and predictors of palliative care consultation in patients with advanced cancer at a tertiary cancer center: secondary analysis of routinely collected health data. Oncologist 25:722–728CrossRef Watanabe SM, Faily V, Mawani A et al (2020) Frequency, timing, and predictors of palliative care consultation in patients with advanced cancer at a tertiary cancer center: secondary analysis of routinely collected health data. Oncologist 25:722–728CrossRef
36.
Zurück zum Zitat Temel JS, Sloan J, Zemla T et al (2020) Multisite, randomized trial of early integrated palliative and oncology care in patients with advanced lung and gastrointestinal cancer: Alliance a221303. J Palliat Med 23:922–929CrossRef Temel JS, Sloan J, Zemla T et al (2020) Multisite, randomized trial of early integrated palliative and oncology care in patients with advanced lung and gastrointestinal cancer: Alliance a221303. J Palliat Med 23:922–929CrossRef
37.
Zurück zum Zitat Costantini M, Beccaro M, Merlo F (2005) The last three months of life of Italian cancer patients. Methods, sample characteristics and response rate of the Italian survey of the dying of cancer. Palliat Med 19:628–638CrossRef Costantini M, Beccaro M, Merlo F (2005) The last three months of life of Italian cancer patients. Methods, sample characteristics and response rate of the Italian survey of the dying of cancer. Palliat Med 19:628–638CrossRef
38.
Zurück zum Zitat Breen LJ, Aoun SM, O’Connor M (2015) The effect of caregiving on bereavement outcome: study protocol for a longitudinal, prospective study. BMC Palliat Care 14:6CrossRef Breen LJ, Aoun SM, O’Connor M (2015) The effect of caregiving on bereavement outcome: study protocol for a longitudinal, prospective study. BMC Palliat Care 14:6CrossRef
39.
Zurück zum Zitat Maciejewski PK, Zhang B, Block SD et al (2007) An empirical examination of the stage theory of grief. JAMA 297:716–723CrossRef Maciejewski PK, Zhang B, Block SD et al (2007) An empirical examination of the stage theory of grief. JAMA 297:716–723CrossRef
40.
Zurück zum Zitat Aoyama M, Morita T, Kizawa Y et al (2017) The Japan hospice and palliative care evaluation study 3: study design, characteristics of participants and participating institutions, and response rates. Am J Hosp Palliat Med 34:654–664CrossRef Aoyama M, Morita T, Kizawa Y et al (2017) The Japan hospice and palliative care evaluation study 3: study design, characteristics of participants and participating institutions, and response rates. Am J Hosp Palliat Med 34:654–664CrossRef
Metadaten
Titel
Appropriate referral timing to specialized palliative care service: survey of bereaved families of cancer patients who died in palliative care units
verfasst von
Keita Tagami
Kento Masukawa
Akira Inoue
Tatsuya Morita
Yusuke Hiratsuka
Mamiko Sato
Katsura Kohata
Noriaki Satake
Yoshiyuki Kizawa
Satoru Tsuneto
Yasuo Shima
Mitsunori Miyashita
Publikationsdatum
21.08.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2022
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06493-2

Weitere Artikel der Ausgabe 1/2022

Supportive Care in Cancer 1/2022 Zur Ausgabe

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.